Current recommendations for the molecular evaluation of newly diagnosed holoprosencephaly patients
Autor: | Véronique David, Daniel E. Pineda-Alvarez, Christèle Dubourg, Erich Roessler, Maximilian Muenke |
---|---|
Přispěvatelé: | Cancer Genetics Branch, National Institute of Health (NIH)-National Human Genome Research Institute (NHGRI), Institut de Génétique et Développement de Rennes (IGDR), Centre National de la Recherche Scientifique (CNRS)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES), Service de Génétique Clinique, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-hôpital Sud, This work was supported by the Division of Intramural Research of the National Human Genome Research Institute, the National Institutes of Health., Université de Rennes (UR)-Centre National de la Recherche Scientifique (CNRS), Service de génétique clinique [Rennes], Université de Rennes (UR)-CHU Pontchaillou [Rennes]-hôpital Sud, De Villemeur, Hervé |
Jazyk: | angličtina |
Rok vydání: | 2010 |
Předmět: |
Pathology
Time Factors [SDV.GEN] Life Sciences [q-bio]/Genetics MESH: Molecular Diagnostic Techniques Bioinformatics MESH: Smith-Lemli-Opitz Syndrome disease genes 0302 clinical medicine Holoprosencephaly MESH: Eye Proteins MESH: Nerve Tissue Proteins [SDV.BDD]Life Sciences [q-bio]/Development Biology Genetics (clinical) 0303 health sciences Nuclear Proteins MESH: Transcription Factors Penetrance MESH: Health Planning Guidelines 3. Good health HPE Molecular Diagnostic Techniques MESH: Holoprosencephaly Algorithms musculoskeletal diseases medicine.medical_specialty congenital hereditary and neonatal diseases and abnormalities Health Planning Guidelines Nerve Tissue Proteins MESH: Algorithms Newly diagnosed Biology ZIC2 Article molecular diagnostics 03 medical and health sciences Neuroimaging [SDV.BDD] Life Sciences [q-bio]/Development Biology MESH: Homeodomain Proteins Genetics medicine Humans MESH: Chromosome Aberrations Hedgehog Proteins multi-factorial inheritance Craniofacial Eye Proteins 030304 developmental biology Chromosome Aberrations Homeodomain Proteins [SDV.GEN]Life Sciences [q-bio]/Genetics MESH: Humans MESH: Time Factors MESH: Hedgehog Proteins medicine.disease Molecular diagnostics Smith-Lemli-Opitz Syndrome holoprosencephaly Smith–Lemli–Opitz syndrome MESH: Nuclear Proteins 030217 neurology & neurosurgery Transcription Factors |
Zdroj: | American Journal of Medical Genetics Part C: Seminars in Medical Genetics American Journal of Medical Genetics Part C: Seminars in Medical Genetics, Wiley, 2010, 154C (1), pp.93-101. ⟨10.1002/ajmg.c.30253⟩ American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2010, 154C (1), pp.93-101. ⟨10.1002/ajmg.c.30253⟩ |
ISSN: | 1552-4868 1552-4876 |
DOI: | 10.1002/ajmg.c.30253⟩ |
Popis: | International audience; Holoprosencephaly (HPE) is the most common structural malformation of the developing forebrain in humans and is typically characterized by different degrees of hemispheric separation that are often accompanied by similarly variable degrees of craniofacial and midline anomalies. HPE is a classic example of a complex genetic trait with "pseudo"-autosomal dominant transmission showing incomplete penetrance and variable expressivity. Clinical suspicion of HPE is typically based upon compatible craniofacial findings, the presence of developmental delay or seizures, or specific endocrinological abnormalities, and is then followed up by confirmation with brain imaging. Once a clinical diagnosis is made, a thorough genetic evaluation is necessary. This usually includes analysis of chromosomes by high-resolution karyotyping, clinical assessment to rule-out well recognized syndromes that are associated with HPE (e.g., Pallister-Hall syndrome, Smith-Lemli-Opitz syndrome and others), and molecular studies of the most common HPE associated genes (e.g., SHH, ZIC2 and SIX3). In this review, we provide current step-by-step recommendations that are medically indicated for the genetic evaluation of patients with newly diagnosed HPE. Moreover, we provide a brief review of several available methods used in molecular diagnostics of HPE and describe the advantages and limitations of both currently available and future tests as they relate to high throughput screening, cost, and the results that they may provide. |
Databáze: | OpenAIRE |
Externí odkaz: |